These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24453714)

  • 1. Validation of the NARCOMS Registry: Tremor and Coordination Scale.
    Marrie RA; Goldman M
    Int J MS Care; 2011; 13(3):114-20. PubMed ID: 24453714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of performance scales for disability assessment in multiple sclerosis.
    Marrie RA; Goldman M
    Mult Scler; 2007 Nov; 13(9):1176-82. PubMed ID: 17623733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
    Chamot E; Kister I; Cutter GR
    BMC Neurol; 2014 Oct; 14():192. PubMed ID: 25278315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales.
    Tang CC; Soh SE; Boonstra F; Noffs G; Kolbe SC; Butzkueven H; Evans A; Van der Walt A
    Mult Scler Relat Disord; 2022 Feb; 58():103495. PubMed ID: 35085981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the NARCOMS registry: fatigue assessment.
    Marrie RA; Cutter G; Tyry T; Hadjimichael O; Campagnolo D; Vollmer T
    Mult Scler; 2005 Oct; 11(5):583-4. PubMed ID: 16193897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes.
    Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Mowry EM; Marrie RA
    Mult Scler Relat Disord; 2019 Apr; 29():86-93. PubMed ID: 30690340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.
    Miller DM; Rudick RA; Cutter G; Baier M; Fischer JS
    Arch Neurol; 2000 Sep; 57(9):1319-24. PubMed ID: 10987899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey.
    Rinker JR; Salter AR; Walker H; Amara A; Meador W; Cutter GR
    BMJ Open; 2015 Jan; 5(1):e006714. PubMed ID: 25573524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and relation of two arm function tests, Box and Blocks test and Nine Hole Peg test, across disease severity levels and types of multiple sclerosis.
    Bertoni R; Cattaneo D; Grosso C; Baglio F; Jonsdottir J
    Mult Scler Relat Disord; 2022 Mar; 59():103683. PubMed ID: 35168094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multiple sclerosis functional composite: a clinically meaningful measure of disability.
    Polman CH; Rudick RA
    Neurology; 2010 Apr; 74 Suppl 3():S8-15. PubMed ID: 20421572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis.
    Tanoh IC; Maillart E; Labauge P; Cohen M; Maarouf A; Vukusic S; Donzé C; Gallien P; De Sèze J; Bourre B; Moreau T; Louapre C; Vallée M; Bieuvelet S; Klaeylé L; Argoud AL; Zinaï S; Tourbah A
    Mult Scler Relat Disord; 2021 Oct; 55():103164. PubMed ID: 34352512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the NARCOMS Registry: pain assessment.
    Marrie RA; Cutter G; Tyry T; Hadjimichael O; Vollmer T
    Mult Scler; 2005 Jun; 11(3):338-42. PubMed ID: 15957517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Multiple Sclerosis Functional Composite and Symbol Digit Modalities Test as outcome measures in pediatric multiple sclerosis.
    Brenton JN; Koshiya H; Woolbright E; Goldman MD
    Mult Scler J Exp Transl Clin; 2019; 5(2):2055217319846141. PubMed ID: 31065380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidimensional assessment of multiple sclerosis: relationships between disability domains.
    Provinciali L; Ceravolo MG; Bartolini M; Logullo F; Danni M
    Acta Neurol Scand; 1999 Sep; 100(3):156-62. PubMed ID: 10478578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SaGAS, the Short and Graphic Ability Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional Composite.
    Vaney C; Vaney S; Wade DT
    Mult Scler; 2004 Apr; 10(2):231-42. PubMed ID: 15124771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.